Articles

Lilly stock shrugs off analyst downgrade

The drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and drug-development setbacks, a Jefferies analyst wrote.

Read More

Indiana sues estate of alleged Ponzi schemer

The state has gone to court to freeze the assets of the estate of a dead Kokomo investment adviser so the money can provide possible restitution to victims of a Ponzi scheme who might include former National Football League players.

Read More

SEC accuses Indy cancer firm of being a sham

The SEC says the CEO of locally based biomedical firm Xytos Inc. has committed securities fraud
since 2010 by repeatedly publishing false information to investors about the company. Timothy Cook denies the accusations.

Read More

NASDAQ breakdown ramps pressure to take actions

The latest high-tech disruption in the financial markets ratchets up the pressure on NASDAQ and other electronic exchanges to take steps to avoid future breakdowns and manage them better if they do occur.

Read More

Mighty Oxford Financial loses big case with client

An arbitrator ordered the Carmel financial-advisory firm to pay $2.2 million to Reid Hospital & Health Services of Richmond. The dispute involved a delay in executing trades in 2011 that the hospital alleged cost it $2.5 million.

Read More